Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB08881"

No prefix for http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/.

Predicate	Value (sorted: none)
ns1:interactsWith	?:Nefazodone
ns1:interactsWith	?:Clarithromycin
owl:sameAs	?:Rifabutin
owl:sameAs	?:Nefazodone
ns1:interactsWith	?:Rifapentine
owl:sameAs	?:Atazanavir
ns1:interactsWith	?:Ketoconazole
ns1:interactsWith	?:Warfarin
ns1:interactsWith	?:Rifabutin
owl:sameAs	?:Telithromycin
owl:sameAs	?:Clarithromycin
owl:sameAs	?:Carbamazepine
ns1:interactsWith	?:Dextromethorphan
owl:sameAs	?:Saquinavir
owl:sameAs	?:Nelfinavir
owl:sameAs	?:Phenytoin
owl:sameAs	?:Ritonavir
owl:sameAs	?:Indinavir
ns1:interactsWith	?:Itraconazole
ns1:interactsWith	?:Rifampicin
ns1:interactsWith	?:Phenobarbital
rdfs:label	"Vemurafenib"
rdf:type	ns1:drugs
owl:sameAs	?:Rifampicin
owl:sameAs	?:Midazolam
owl:sameAs	?:Caffeine
ns1:interactsWith	?:Caffeine
ns1:interactsWith	?:Indinavir
owl:sameAs	?:Warfarin
owl:sameAs	?:Ketoconazole
ns1:interactsWith	?:Midazolam
ns1:interactsWith	?:Atazanavir
owl:sameAs	?:Voriconazole
owl:sameAs	?:Phenobarbital
ns1:description	"Vemurafenib is a BRAF enzyme inhibitor developed by Plexxikon and Genentech for the treatment of late-stage melanoma. [Wikipedia] The cobas® 4800 BRAF B600 mutation test provided by Roche Molecular Systems is the diagnostic test to confirm eligibility for treatment. FDA approved on August 17, 2011 under the company Hoffmann La Roche. "
owl:sameAs	?:Rifapentine
ns1:interactsWith	?:Nelfinavir
ns1:interactsWith	?:Saquinavir
ns1:interactsWith	?:Ritonavir
owl:sameAs	?:Itraconazole
ns1:interactsWith	?:Telithromycin
owl:sameAs	?:Dextromethorphan
ns1:interactsWith	?:Carbamazepine
ns1:interactsWith	?:Phenytoin
ns1:interactsWith	?:Voriconazole

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt

The resource appears as object in 42 triples

Context graph